SHH and familial pancreatic carcinoma: However, Shh inhibitors have also been shown to increase tumor growth in mouse models of pancreatic cancer and pancreatic intraepithelial neoplasia (PanIN) progression (Lee et al., 2014; Rhim et al., 2014).